about
TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancyPanic Attack during Elective Gastrointestinal Endoscopy.A cervical abnormality risk prediction model: can we use clinical information to predict which patients with ASCUS/LSIL Pap tests will develop CIN 2/3 or AIS?A systematic review of p16/Ki-67 immuno-testing for triage of low grade cervical cytology.Influences on human papillomavirus (HPV)-related information needs among women having HPV tests for follow-up of abnormal cervical cytology.The precision prevention and therapy of HPV-related cervical cancer: new concepts and clinical implications
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Adverse outcomes after colposcopy.
@ast
Adverse outcomes after colposcopy.
@en
type
label
Adverse outcomes after colposcopy.
@ast
Adverse outcomes after colposcopy.
@en
prefLabel
Adverse outcomes after colposcopy.
@ast
Adverse outcomes after colposcopy.
@en
P2093
P2860
P356
P1433
P1476
Adverse outcomes after colposcopy.
@en
P2093
David Luesley
Sarah L Damery
Sarah M Flanagan
Sheila M Greenfield
Sue Wilson
P2860
P2888
P356
10.1186/1472-6874-11-2
P577
2011-01-20T00:00:00Z
P5875
P6179
1026189764